Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Inflammation Related Mirnas As an Important Player Between Obesity and Cancers Publisher



Gholami M1, 2 ; Larijani B2 ; Zahedi Z2 ; Mahmoudian F3 ; Bahrami S4 ; Omran SP5 ; Saadatian Z6 ; Hasaniranjbar S1 ; Taslimi R7 ; Bastami M8 ; Amoli MM5
Authors

Source: Journal of Diabetes and Metabolic Disorders Published:2019


Abstract

The growing trend in addition to their burden, prevalence, and death has made obesity and cancer two of the most concerning diseases worldwide. Obesity is an important risk factor for common types of cancers where the risk of some cancers is directly related to the obesity. Various inflammatory mechanisms and increased level of pro-inflammatory cytokines have been investigated in many previous studies, which play key roles in the pathophysiology and development of both of these conditions. On the other hand, in the recent years, many studies have individually focused on the biomarker’s role and therapeutic targeting of microRNAs (miRNAs) in different types of cancers and obesity including newly discovered small noncoding RNAs (sncRNAs) which regulate gene expression and RNA silencing. This study is a comprehensive review of the main inflammation related miRNAs in obesity/obesity related traits. For the first time, the main roles of miRNAs in obesity related cancers have been discussed in response to the question raised in the following hypothesis; do the main inflammatory miRNAs link obesity with obesity-related cancers regarding their role as biomarkers? [Figure not available: see fulltext.]. © 2019, Springer Nature Switzerland AG.
Other Related Docs
5. Exosomes and Micrornas in Biomedical Science, Synthesis Lectures on Biomedical Engineering (2022)
9. Cancer Genetics at a Glance: The Comprehensive Insights, Cancer Genetics and Psychotherapy (2017)
12. Targeting Mirna by Natural Products: A Novel Therapeutic Approach for Nonalcoholic Fatty Liver, Evidence-based Complementary and Alternative Medicine (2021)